ArticleRheumatology (Oxford, England)2018

Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials: reply.

Monica S M Persson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.